Brian C Stephenson Bridge Bio Pharma, Inc. (BBIO) insider trading activity

Brian C Stephenson is Secretary, Treasurer & CFO of BridgeBio Pharma, Inc.. Currently has a direct ownership of 102,464 shares of BBIO, which is worth approximately $3.72 Million. The most recent transaction as insider was on Feb 19, 2025, when has been sold 4,148 shares (Common Stock) at a price of $36.16 per share, resulting in proceeds of $149,991. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 102K

9.29% 3M change

62.88% 12M change

Total Value Held $3.72 Million

BRIAN C STEPHENSON Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Feb 19 2025	SELL Open market or private sale	$149,991 $36.16 p/Share	4,148 Reduced 3.89%	102,464 Common Stock
Feb 16 2025	SELL Payment of exercise price or tax liability	$457,259 $34.9 p/Share	13,102 Reduced 10.94%	106,612 Common Stock
Feb 16 2025	BUY Exercise of conversion of derivative security	-	25,798 Added 17.73%	119,714 Common Stock
Jan 28 2025	SELL Open market or private sale	$2,467,720 $36.29 p/Share	68,000 Reduced 42.04%	93,758 Common Stock
Jan 28 2025	BUY Exercise of conversion of derivative security	$1,156,000 $17.0 p/Share	68,000 Added 29.6%	161,758 Common Stock
Nov 19 2024	SELL Open market or private sale	$93,135 $22.41 p/Share	4,156 Reduced 4.24%	93,758 Common Stock
Nov 16 2024	SELL Payment of exercise price or tax liability	$310,186 $23.72 p/Share	13,077 Reduced 11.78%	97,914 Common Stock
Nov 16 2024	BUY Exercise of conversion of derivative security	-	25,799 Added 18.86%	110,991 Common Stock
Aug 19 2024	SELL Open market or private sale	$102,877 $24.76 p/Share	4,155 Reduced 4.65%	85,192 Common Stock
Aug 16 2024	SELL Payment of exercise price or tax liability	$319,078 $24.4 p/Share	13,077 Reduced 12.77%	89,347 Common Stock
Aug 16 2024	BUY Exercise of conversion of derivative security	-	25,797 Added 20.12%	102,424 Common Stock
May 16 2024	SELL Payment of exercise price or tax liability	$432,790 $31.04 p/Share	13,943 Reduced 15.42%	76,472 Common Stock
May 16 2024	BUY Exercise of conversion of derivative security	-	27,507 Added 23.33%	90,415 Common Stock
Feb 16 2024	SELL Payment of exercise price or tax liability	$703,975 $37.21 p/Share	18,919 Reduced 23.12%	62,908 Common Stock
Feb 16 2024	BUY Exercise of conversion of derivative security	-	44,996 Added 35.48%	81,827 Common Stock
Nov 17 2023	SELL Open market or private sale	$660,133 $29.1 p/Share	22,685 Reduced 38.19%	36,710 Common Stock
Nov 16 2023	SELL Payment of exercise price or tax liability	$643,895 $28.86 p/Share	22,311 Reduced 27.31%	59,395 Common Stock
Nov 16 2023	BUY Exercise of conversion of derivative security	-	44,996 Added 35.51%	81,706 Common Stock
Aug 17 2023	SELL Open market or private sale	$648,506 $28.59 p/Share	22,683 Reduced 38.19%	36,710 Common Stock
Aug 16 2023	SELL Payment of exercise price or tax liability	$664,867 $29.8 p/Share	22,311 Reduced 27.31%	59,393 Common Stock
Aug 16 2023	BUY Exercise of conversion of derivative security	-	44,994 Added 35.51%	81,704 Common Stock
May 17 2023	SELL Open market or private sale	$342,180 $14.01 p/Share	24,424 Reduced 40.15%	36,408 Common Stock
May 16 2023	SELL Payment of exercise price or tax liability	$289,859 $14.09 p/Share	20,572 Reduced 25.27%	60,832 Common Stock
May 16 2023	BUY Exercise of conversion of derivative security	-	44,996 Added 35.6%	81,404 Common Stock
May 03 2023	SELL Open market or private sale	$920,693 $14.18 p/Share	64,929 Reduced 64.07%	36,408 Common Stock

BCS

Brian C Stephenson

Secretary, Treasurer & CFO

Palo Alto, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells BBIO shares.

Notify only if

Value

Insider Trading

Get notified when an Bridge Bio Pharma, Inc. insider buys or sells BBIO shares.

Notify only if

Operation

Value

Type

News

Receive news related to BridgeBio Pharma, Inc.

Track Activities on BBIO

Account